The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
The Pathogenesis of the Antiphospholipid Syndrome
Abstract
The antiphospholipid syndrome is a prothrombotic disorder associated with autoantibodies. It is associated with obstetrical complications (mainly spontaneous abortion) as well as venous and arterial thrombotic risks. Insights into disease mechanisms have led to new therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
Self-citationBeckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Vascular endothelial cells synthesize nitric oxide from L-arginine
Palmer, R. M. J., Ashton, D. S., & Moncada, S. (1988) · Nature · doi:10.1038/333664a0 · Cited by 4,769
Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
De Caterina, R., Libby, P., Peng, H. B., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A., Shin, W. S., & Liao, J. K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118074 · Cited by 1,782
McNeil, H. P., Simpson, R. J., Chesterman, C. N., & Krilis, S. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.11.4120 · Cited by 1,595
Self-citationENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUM
Radomski, M. W., Palmer, R. M. J., & Moncada, S. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91481-4 · Cited by 1,437
Love, P. E., & Santoro, S. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-682 · Cited by 1,095
Christensen, S. R., Shupe, J., Nickerson, K., Kashgarian, M., Flavell, R. A., & Shlomchik, M. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.013 · Cited by 1,090
Galli, M., Luciani, D., Bertolini, G., & Barbui, T. (2003) · Blood · doi:10.1182/blood-2002-02-0441 · Cited by 972
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication
Pisitkun, P., Deane, J. A., Difilippantonio, M. J., Tarasenko, T., Satterthwaite, A. B., & Bolland, S. (2006) · Science · doi:10.1126/science.1124978 · Cited by 894
Ruiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
High Levels of Coagulation Factor XI as a Risk Factor for Venous Thrombosis
Meijers, J. C. M., Tekelenburg, W. L. H., Bouma, B. N., Bertina, R. M., & Rosendaal, F. R. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421004 · Cited by 700
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 626
Pathogenesis of antiphospholipid syndrome: understanding the antibodies
Meroni, P. L., Borghi, M. O., Raschi, E., & Tedesco, F. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.52 · Cited by 620
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines
Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000702 · Cited by 606
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Lauer, T., Preik, M., Rassaf, T., Strauer, B. E., Deussen, A., Feelisch, M., & Kelm, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221381098 · Cited by 585
Bevers, E. M., Galli, M., Barbui, T., Comfurius, P., & Zwaal, R. F. A. (1991) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1646476 · Cited by 576
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Pregnancy Loss in the Antiphospholipid-Antibody Syndrome — A Possible Thrombogenic Mechanism
Rand, J. H., Wu, X.-X., Andree, H. A. M., Lockwood, C. J., Guller, S., Scher, J., & Harpel, P. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370303 · Cited by 526
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
Pengo, V., Ruffatti, A., Legnani, C., Testa, S., Fierro, T., Marongiu, F., De Micheli, V., Gresele, P., Tonello, M., Ghirarduzzi, A., et al. (2011) · Blood · doi:10.1182/blood-2011-03-340232 · Cited by 468
Urbanus, R. T., Siegerink, B., Roest, M., Rosendaal, F. R., de Groot, P. G., & Algra, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70239-x · Cited by 429
Lockshin, M. D., Kim, M., Laskin, C. A., Guerra, M., Branch, D. W., Merrill, J., Petri, M., Porter, T. F., Sammaritano, L., Stephenson, M. D., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34402 · Cited by 388
de Laat, B., Derksen, R. H. W. M., Urbanus, R. T., & de Groot, P. G. (2005) · Blood · doi:10.1182/blood-2004-09-3387 · Cited by 378
Pierangeli, S. S., Girardi, G., Vega‐Ostertag, M., Liu, X., Espinola, R. G., & Salmon, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21157 · Cited by 362
Cervera, R., Bucciarelli, S., Plasín, M. A., Gómez-Puerta, J. A., Plaza, J., Pons-Estel, G., Shoenfeld, Y., Ingelmo, M., & Espinos, G. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.008 · Cited by 358
Fischetti, F., Durigutto, P., Pellis, V., Debeus, A., Macor, P., Bulla, R., Bossi, F., Ziller, F., Sblattero, D., Meroni, P., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1319 · Cited by 351
Schwarzenbacher, R., Zeth, K., Diederichs, K., Gries, A., Kostner, G. M., Laggner, P., & Prassl, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.22.6228 · Cited by 311
Raschi, E., Testoni, C., Bosisio, D., Borghi, M. O., Koike, T., Mantovani, A., & Meroni, P. L. (2003) · Blood · doi:10.1182/blood-2002-08-2349 · Cited by 306
Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents
Jasuja, R., Passam, F. H., Kennedy, D. R., Kim, S. H., van Hessem, L., Lin, L., Bowley, S. R., Joshi, S. S., Dilks, J. R., Furie, B., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61228 · Cited by 304
Wahl, D., Guillemin, F., de Maistre, E., Perret, C., Lecompte, T., & Thibaut, G. (1997) · Lupus · doi:10.1177/096120339700600510 · Cited by 285
Ağar, Ç., van Os, G. M. A., Mörgelin, M., Sprenger, R. R., Marquart, J. A., Urbanus, R. T., Derksen, R. H. W. M., Meijers, J. C. M., & de Groot, P. G. (2010) · Blood · doi:10.1182/blood-2009-12-260976 · Cited by 263
Otomo, K., Atsumi, T., Amengual, O., Fujieda, Y., Kato, M., Oku, K., Horita, T., Yasuda, S., & Koike, T. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33340 · Cited by 254
Rand, J. H., Wu, X.-X., Quinn, A. S., Ashton, A. W., Chen, P. P., Hathcock, J. J., Andree, H. A. M., & Taatjes, D. J. (2010) · Blood · doi:10.1182/blood-2009-04-213520 · Cited by 253
Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice
Edwards, M. H., Pierangeli, S., Liu, X., Barker, J. H., Anderson, G., & Harris, E. N. (1997) · Circulation · doi:10.1161/01.cir.96.12.4380 · Cited by 250
N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
Chen, J., Reheman, A., Gushiken, F. C., Nolasco, L., Fu, X., Moake, J. L., Ni, H., & López, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41062 · Cited by 234
Vega‐Ostertag, M., Casper, K., Swerlick, R., Ferrara, D., Harris, E. N., & Pierangeli, S. S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21009 · Cited by 226
Sorice, M., Longo, A., Capozzi, A., Garofalo, T., Misasi, R., Alessandri, C., Conti, F., Buttari, B., Riganò, R., Ortona, E., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22802 · Cited by 221
Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies
Pierangeli, S. S., Vega-Ostertag, M. E., Raschi, E., Liu, X., Romay-Penabad, Z., De Micheli, V., Galli, M., Moia, M., Tincani, A., Borghi, M. O., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.065037 · Cited by 220
de Laat, H. B., Derksen, R. H. W. M., Urbanus, R. T., Roest, M., & de Groot, P. G. (2004) · Blood · doi:10.1182/blood-2004-03-1107 · Cited by 219
High Affinity Binding of β2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II
Ma, K., Simantov, R., Zhang, J.-C., Silverstein, R., Hajjar, K. A., & McCrae, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15541 · Cited by 214
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis
DE GROOT, P. G., LUTTERS, B., DERKSEN, R. H. W. M., LISMAN, T., MEIJERS, J. C. M., & ROSENDAAL, F. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01485.x · Cited by 205
Tucker, E. I., Marzec, U. M., White, T. C., Hurst, S., Rugonyi, S., McCarty, O. J. T., Gailani, D., Gruber, A., & Hanson, S. R. (2009) · Blood · doi:10.1182/blood-2008-06-163675 · Cited by 204
López‐Pedrera, C., Buendía, P., José Cuadrado, M., Siendones, E., Angeles Aguirre, M., Barbarroja, N., Montiel‐Duarte, C., Torres, A., Khamashta, M., & Velasco, F. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21549 · Cited by 203
Roubey, R. A., Pratt, C. W., Buyon, J. P., & Winfield, J. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115926 · Cited by 203
Shapira, I., Andrade, D., Allen, S. L., & Salmon, J. E. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34440 · Cited by 200
Delgado Alves, J., Ames, P. R. J., Donohue, S., Stanyer, L., Noorouz‐Zadeh, J., Ravirajan, C., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10542 · Cited by 199
Ramesh, S., Morrell, C. N., Tarango, C., Thomas, G. D., Yuhanna, I. S., Girardi, G., Herz, J., Urbanus, R. T., de Groot, P. G., Thorpe, P. E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci39828 · Cited by 194
Kobayashi, K., Kishi, M., Atsumi, T., Bertolaccini, M. L., Makino, H., Sakairi, N., Yamamoto, I., Yasuda, T., Khamashta, M. A., Hughes, G. R. V., et al. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200329-jlr200 · Cited by 188
Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome
Hashimoto, Y., Kawamura, M., Ichikawa, K., Suzuki, T., Sumida, T., Yoshida, S., Matsuura, E., Ikehara, S., & Koike, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.3.1063 · Cited by 186
Shi, T., Giannakopoulos, B., Yan, X., Yu, P., Berndt, M. C., Andrews, R. K., Rivera, J., Iverson, G. M., Cockerill, K. A., Linnik, M. D., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21968 · Cited by 167
Self-citationEculizumab and Renal Transplantation in a Patient with CAPS
Lonze, B. E., Singer, A. L., & Montgomery, R. A. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910965 · Cited by 162
Iverson, G. M., Reddel, S., Victoria, E. J., Cockerill, K. A., Wang, Y.-X., Martí-Renom, M. A., Šali, A., Marquis, D. M., Krilis, S. A., & Linnik, M. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7097 · Cited by 153
Self-citationCharakida, M. (2009) · JAMA · doi:10.1001/jama.2009.1346 · Cited by 152
Ferrara, D. E., Liu, X., Espinola, R. G., Meroni, P. L., Abukhalaf, I. K., Harris, E. N., & Pierangeli, S. S. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11449 · Cited by 144
Allen, K. L., Fonseca, F. V., Betapudi, V., Willard, B. B., Zhang, J., & McCrae, K. R. (2011) · Blood · doi:10.1182/blood-2011-03-344671 · Cited by 142
Arad, A., Proulle, V., Furie, R. A., Furie, B. C., & Furie, B. (2011) · Blood · doi:10.1182/blood-2010-08-300715 · Cited by 140
In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions
Agostinis, C., Biffi, S., Garrovo, C., Durigutto, P., Lorenzon, A., Bek, A., Bulla, R., Grossi, C., Borghi, M. O., Meroni, P. L., et al. (2011) · Blood · doi:10.1182/blood-2011-01-333617 · Cited by 139
Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo
Romay‐Penabad, Z., Montiel-Manzano, M. G., Shilagard, T., Papalardo, E., Vargas, G., Deora, A. B., Wang, M., Jacovina, A. T., García-Latorre, E., Reyes‐Maldonado, E., et al. (2009) · Blood · doi:10.1182/blood-2008-11-188698 · Cited by 134
Ioannou, Y., Penabad, Z. R., Pericleous, C., Giles, I., Papalardo, E., Vargas, G., Shilagard, T., Latchman, D. S., Isenberg, D. A., Rahman, A., et al. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03316.x · Cited by 132
Urbanus, R. T., Pennings, M. T. T., Derksen, R. H. W. M., & de Groot, P. G. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03021.x · Cited by 130
Romay‐Penabad, Z., Aguilar‐Valenzuela, R., Urbanus, R. T., Derksen, R. H. W. M., Pennings, M. T. T., Papalardo, E., Shilagard, T., Vargas, G., Hwang, Y. G., de Groot, P. G., et al. (2010) · Blood · doi:10.1182/blood-2010-07-299099 · Cited by 126
de Laat, B., Wu, X.-X., van Lummel, M., Derksen, R. H. W. M., de Groot, P. G., & Rand, J. H. (2007) · Blood · doi:10.1182/blood-2006-07-030148 · Cited by 122
Ioannou, Y., Zhang, J.-Y., Passam, F. H., Rahgozar, S., Qi, J. C., Giannakopoulos, B., Qi, M., Yu, P., Yu, D. M., Hogg, P. J., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215335 · Cited by 121
Self-citationFactor XI and XII as antithrombotic targets
Müller, F., Gailani, D., & Renné, T. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283497e61 · Cited by 120
Prinz, N., Clemens, N., Strand, D. J., Pütz, I., Lorenz, M., Daiber, A., Stein, P., Degreif, A., Radsak, M. P., Schild, H., et al. (2011) · Blood · doi:10.1182/blood-2011-01-330639 · Cited by 119
Prevention of murine antiphospholipid syndrome by BAFF blockade
Kahn, P. J., Ramanujam, M., Bethunaickan, R., Huang, W., Tao, H., Madaio, M. P., Factor, S. M., & Davidson, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23764 · Cited by 117
Ioannou, Y., Zhang, J., Qi, M., Gao, L., Qi, J. C., Yu, D., Lau, H., Sturgess, A. D., Vlachoyiannopoulos, P. G., Moutsopoulos, H. Μ., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30383 · Cited by 110
Self-citationGris, J., Bouvier, S., Molinari, N., Galanaud, J. ‐., Cochery-Nouvellon, É., Mercier, É., Fabbro-Péray, P., Balducchi, J.-P., Marès, P., Quéré, I., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381913 · Cited by 110
Sikara, M. P., Routsias, J. G., Samiotaki, M. K., Panayotou, G., Moutsopoulos, H. Μ., & Vlachoyiannopoulos, P. G. (2009) · Blood · doi:10.1182/blood-2009-03-206367 · Cited by 108
Satta, N., Kruithof, E. K. O., Fickentscher, C., Dunoyer-Geindre, S., Boehlen, F., Reber, G., Burger, D., & de Moerloose, P. (2011) · Blood · doi:10.1182/blood-2010-11-316158 · Cited by 107
BRODER, A., & PUTTERMAN, C. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120157 · Cited by 102
Pérez‐Sánchez, C., Ruiz‐Limón, P., Aguirre, M. A., Bertolaccini, M. L., Khamashta, M. A., Rodríguez‐Ariza, A., Segui, P., Collantes‐Estévez, E., Barbarroja, N., Khraiwesh, H. M., et al. (2012) · Blood · doi:10.1182/blood-2011-12-400986 · Cited by 100
Epitope Studies with Anti-β2-glycoprotein I Antibodies from Autoantibody and Immunized Sources
Reddel, S., Wang, Y. X., Sheng, Y., & Krilis, S. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0427 · Cited by 96
Self-citationDevreese, K., Peerlinck, K., & Hoylaerts, M. F. (2010) · Blood · doi:10.1182/blood-2009-09-244426 · Cited by 93
Annexin A2 is a novel Cellular Redox Regulatory Protein involved in Tumorigenesis
Madureira, P. A., Hill, R., Miller, V. A., Giacomantonio, C. A., Lee, P. W. K., & Waisman, D. M. (2011) · Oncotarget · doi:10.18632/oncotarget.375 · Cited by 91
Asherson, R. (1998) · Lupus · doi:10.1177/096120339800700214 · Cited by 85
Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
GALLI, M., REBER, G., DE MOERLOOSE, P., & DE GROOT, P. G. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.02862.x · Cited by 85
Nishimura, S., Manabe, I., Nagasaki, M., Kakuta, S., Iwakura, Y., Takayama, N., Ooehara, J., Otsu, M., Kamiya, A., Petrich, B. G., et al. (2011) · Blood · doi:10.1182/blood-2011-09-381400 · Cited by 84
Banzato, A., Pozzi, N., Frasson, R., Filippis, V. D., Ruffatti, A., Bison, E., Jose, S. P., Denas, G., & Pengo, V. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.021 · Cited by 83
Seshan, S. V., Franzke, C.-W., Redecha, P. B., Monestier, M., Mackman, N., & Girardi, G. (2009) · Blood · doi:10.1182/blood-2009-01-199117 · Cited by 80
Lambrianides, A., Carroll, C. J., Pierangeli, S. S., Pericleous, C., Branch, W. D., Rice, J., Latchman, D. S., Townsend, P. A., Isenberg, D. A., Rahman, A., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902765 · Cited by 79
Beta 2 glycoprotein I is a substrate of thiol oxidoreductases
Passam, F. H., Rahgozar, S., Qi, M., Raftery, M. J., Wong, J. W. H., Tanaka, K., Ioannou, Y., Zhang, J. Y., Gemmell, R., Qi, J. C., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271494 · Cited by 70
Self-citationMontiel-Manzano, G., Romay‐Penabad, Z., de Martinez, E. P., Meillón‐García, L. A., García-Latorre, E., Reyes‐Maldonado, E., & Pierangeli, S. S. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1422.057 · Cited by 67
Redox control of β2‐glycoprotein I–von Willebrand factor interaction by thioredoxin‐1
Passam, F. H., Rahgozar, S., QI, M., Raftery, M. J., Wong, J. W. H., Tanaka, K., Ioannou, Y., Zhang, J. Y., Gemmell, R., QI, J. C., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03944.x · Cited by 57
Self-citationAmes, P. R. J., Batuca, J. R., Ciampa, A., Iannaccone, L., & Alves, J. D. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.100494 · Cited by 55
Giannakopoulos, B., Gao, L., Qi, M., Wong, J. W. H., Yu, D. M., Vlachoyiannopoulos, P. G., Moutsopoulos, H. M., Atsumi, T., Koike, T., Hogg, P. J., et al. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.005 · Cited by 52
Self-citationBruce, I. N., Clark-Soloninka, C. A., Spitzer, K. A., Gladman, D. D., Urowitz, M. B., & Laskin, C. A. (2000) · PubMed · Cited by 52
BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus
Fairfax, K. A., Mackay, I. R., & Mackay, F. (2012) · IUBMB Life · doi:10.1002/iub.1046 · Cited by 46
Induction of anti‐β2‐glycoprotein I autoantibodies in mice by protein H of Streptococcus pyogenes
OS, G. M. A. V., Meijers, J. C. M., Ağar, Ç., Serón, M. V., Marquart, J. A., Åkesson, P., Urbanus, R. T., Derksen, R. H. W. M., Herwald, H., Mörgelin, M., et al. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04532.x · Cited by 42
Lee, C., Biasio, A. D., & Beglova, N. (2010) · Structure · doi:10.1016/j.str.2009.12.013 · Cited by 33
Thiol pathways in the regulation of tissue factor prothrombotic activity
Versteeg, H. H., & Ruf, W. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32834981de · Cited by 32
Kolyada, A. Y., Lee, C., Biasio, A. D., & Beglova, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015345 · Cited by 31
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Diagnosis and management of the antiphospholipid syndrome
Garcia, D., & Erkan, D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705454 · Cited by 819
Fakhouri, F., Zuber, J., Frémeaux-Bacchi, V., & Loirat, C. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30062-4 · Cited by 571
The microbiome in autoimmune diseases
De Luca, F., & Shoenfeld, Y. (2018) · Clinical and Experimental Immunology · doi:10.1111/cei.13158 · Cited by 510
Metadata
- Authors
- Giannakopoulos, B., & Krilis, S. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-14
- Volume
- 368
- Issue
- 11
- Pages
- 1033-1044
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2023929943
- Cited by
- 688
- References
- 100
- FWCI
- 53.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.